21/06/2024 Healthcare
Teicoplanin Injection IP, sold under the brand Satcopin-400 Injection, is a glycopeptide antibiotic used for treating severe bacterial infections, particularly those resistant to other antibiotics. Administered intravenously, it targets Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Satcopin-400 Injection offers prolonged antibacterial activity with less frequent dosing due to its long half-life. It is essential in hospital settings for treating complicated infections, ensuring effective therapy against resistant pathogens.Available in PCD Franchise for injectable range and third party manufacturing.
Ticocin 200mg Injection is an antibiotic used in the treatment of severe bacterial infections in hospitalized patients. It is effective against infect...
Onekrit offers a trusted range of critical care injections and critical care injectables. Our products are specifically designed for fast and effectiv...
Discover premium critical care injectables and critical care PCD franchise opportunities with OneKrit — a trusted partner offering WHO-GMP certified p...
OneKrit offers high-quality Injectable Range Franchise opportunities for critically ill patients. Our Critical Care Injectables formulations deliver b...
More Details